Quick Answer
60 DEGREES PHARMACEUTICALS, INC. reported Total Revenue of $1.01 million for the year ending 2025.
- 60 DEGREES PHARMACEUTICALS, INC. showed an increase of +65.5% in Total Revenue from 2024 to 2025.
- This data is from 60 DEGREES PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: $45.2 thousand | Q3 2022: $168.2 thousand | Q1 2023: $17.2 thousand | Q2 2023: $59.5 thousand | Q3 2023: $51.2 thousand | Q1 2024: $105.7 thousand | Q2 2024: $125.0 thousand | Q3 2024: $135.3 thousand | Q1 2025: $163.6 thousand | Q2 2025: $100.9 thousand | Q3 2025: $437.6 thousand.
- Over the full 4 years of available data (2022 to 2025), 60 DEGREES PHARMACEUTICALS, INC.'s Total Revenue has grown by 350.5%.
- Historical annual values: Fiscal year 2025: $1.01 million | Fiscal year 2024: $607.6 thousand | Fiscal year 2023: $253.6 thousand | Fiscal year 2022: $223.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: